Cortica, a technology-enabled autism treatment provider, has raised $60 million in an oversubscribed Series C funding round, the company announced Tuesday.
Longitude Capital led the round, with additional participation from new and existing investors such as Questa Capital, Aperture Venture Partners, 406 Ventures and Adam Boehler, who is the CEO of health care investment firm Rubicon Partners and the founder of in-home care company Landmark Health.
Additionally, Silicon Valley Bank participated in the round by expanding Cortica’s credit facilities.
Founded in 2014, the San Diego-based Cortica provides clinical care at seven locations in Southern California, one in Northern California and another in the Dallas suburb of Plano, Texas. In addition to center-based care, Cortica also provides in-home and telehealth treatment.
Cortica provides comprehensive autism care by blending together a number of different offerings. Those include neurophysiological treatments like nerve and brain stimulation, along with therapies such as applied behavioral analysis (ABA) and speech therapy. It also offers services related to family wellness, food and nutrition, speech and language and more.
The company accepts various major commercial insurance plans.
Cortica has plans to use its new funding to expand its services to new locations, according to a press release announcing the news.
Additionally, Cortica announced that Boehler and former Optum Behavioral Health CEO Martha Temple are joining the company’s board of directors.
“I am honored to have investors and board members with a proven record of success and an unwavering commitment to helping children with neurodevelopmental differences,” Neil Hattangadi, Cortica’s co-founder and CEO, said in the press release. “These partners will help us accelerate the rollout of our autism care centers nationally, as well as support ongoing innovation for clinical care delivery and the family experience.”